Bueno-Fortes Santiago, Muenzner Julienne K, Berral-Gonzalez Alberto, Hampel Chuanpit, Lindner Pablo, Berninger Alexandra, Huebner Kerstin, Kunze Philipp, Bäuerle Tobias, Erlenbach-Wuensch Katharina, Sánchez-Santos José Manuel, Hartmann Arndt, De Las Rivas Javier, Schneider-Stock Regine
Bioinformatics and Functional Genomics Group, Cancer Research Center (CiC-IMBCC, CSIC/USAL/IBSAL), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), 37007 Salamanca, Spain.
Experimental Tumor Pathology, University Hospital of the Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Cancers (Basel). 2021 Dec 28;14(1):136. doi: 10.3390/cancers14010136.
The epithelial-mesenchymal transition (EMT) is associated with tumor aggressiveness and increased invasion, migration, metastasis, angiogenesis, and drug resistance. Although the HCT116 p21-/- cell line is well known for its EMT-associated phenotype, with high Vimentin and low E-cadherin protein levels, the gene signature of this rather intermediate EMT-like cell line has not been determined so far. In this work, we present a robust molecular and bioinformatics analysis, to reveal the associated gene expression profile and its correlation with different types of colorectal cancer tumors. We compared the quantitative signature obtained with the NanoString platform with the expression profiles of colorectal cancer (CRC) Consensus Molecular Subtypes (CMS) as identified, and validated the results in a large independent cohort of human tumor samples. The expression signature derived from the p21-/- cells showed consistent and reliable numbers of upregulated and downregulated genes, as evaluated with two machine learning methods against the four CRC subtypes (i.e., CMS1, 2, 3, and 4). High concordance was found between the upregulated gene signature of HCT116 p21-/- cells and the signature of the CMS4 mesenchymal subtype. At the same time, the upregulated gene signature of the native HCT116 cells was similar to that of CMS1. Using a multivariate Cox regression model to analyze the survival data in the CRC tumor cohort, we selected genes that have a predictive risk power (with a significant score). A set of genes of the mesenchymal signature was proven to be significantly associated with poor survival, specifically in the CMS4 CRC human cohort. We suggest that the gene signature of HCT116 p21-/- cells could be a suitable metric for mechanistic studies regarding the CMS4 signature and its functional consequences in CRC. Moreover, this model could help to discover the molecular mechanisms of intermediate EMT, which is known to be associated with extraordinarily high stemness and drug resistance.
上皮-间质转化(EMT)与肿瘤侵袭性以及侵袭、迁移、转移、血管生成和耐药性增加有关。尽管HCT116 p21-/-细胞系以其与EMT相关的表型而闻名,波形蛋白水平高而E-钙黏蛋白蛋白水平低,但这种相当中间的EMT样细胞系的基因特征迄今尚未确定。在这项工作中,我们进行了强有力的分子和生物信息学分析,以揭示相关的基因表达谱及其与不同类型结直肠癌肿瘤的相关性。我们将用NanoString平台获得的定量特征与已确定的结直肠癌(CRC)共识分子亚型(CMS)的表达谱进行了比较,并在一个大型独立的人类肿瘤样本队列中验证了结果。从p21-/-细胞衍生的表达特征显示,针对四种CRC亚型(即CMS1、2、3和4),用两种机器学习方法评估时,上调和下调基因的数量一致且可靠。发现HCT116 p21-/-细胞的上调基因特征与CMS4间质亚型的特征高度一致。同时,天然HCT116细胞的上调基因特征与CMS1相似。使用多变量Cox回归模型分析CRC肿瘤队列中的生存数据,我们选择了具有预测风险能力(得分显著)的基因。一组间质特征基因被证明与不良生存显著相关,特别是在CMS4 CRC人类队列中。我们认为,HCT116 p21-/-细胞的基因特征可能是关于CMS4特征及其在CRC中的功能后果的机制研究的合适指标。此外,该模型有助于发现中间EMT的分子机制,已知中间EMT与极高的干性和耐药性有关。